# Filing Detail

Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001104659-23-105297
Filing Date
2023-09-29
Accepted
2023-09-29 16:01:43
Documents
30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B4 | tm2225088-43_424b4.htm | 424B4 | 5462284
2 | GRAPHIC | lg_adlainortye-4c.jpg | GRAPHIC | 24298
3 | GRAPHIC | tm2225088d1-tbl_pipelin4c.jpg | GRAPHIC | 267446
4 | GRAPHIC | fc_ourcorporate-bw.jpg | GRAPHIC | 184117
5 | GRAPHIC | tm2225088d1-pht_head4clr.jpg | GRAPHIC | 99868
6 | GRAPHIC | tm2225088d1-pht_action4c.jpg | GRAPHIC | 226083
7 | GRAPHIC | tm2225088d1-tbl_summary4clr.jpg | GRAPHIC | 206202
8 | GRAPHIC | tm2225088d1-lc_activity4clr.jpg | GRAPHIC | 97646
9 | GRAPHIC | tm2225088d1-lc_survival4clr.jpg | GRAPHIC | 115579
10 | GRAPHIC | tm2225088d1-lc_data4clr.jpg | GRAPHIC | 131803
11 | GRAPHIC | tm2225088d1-pht_mechani4c.jpg | GRAPHIC | 242350
12 | GRAPHIC | tm2225088d1-lc_summary4clr.jpg | GRAPHIC | 151375
13 | GRAPHIC | tm2225088d1-lc_antitum4clr.jpg | GRAPHIC | 279086
14 | GRAPHIC | tm2225088d1-pht_ration4c.jpg | GRAPHIC | 226649
15 | GRAPHIC | tm2225088d1-lc_triple4c.jpg | GRAPHIC | 232423
16 | GRAPHIC | tm2225088d1-lc_combinat4clr.jpg | GRAPHIC | 162450
17 | GRAPHIC | tm2225088d1-pht_mechan4clr.jpg | GRAPHIC | 95869
18 | GRAPHIC | tm2225088d1-lc_model4clr.jpg | GRAPHIC | 144856
19 | GRAPHIC | tm2225088d1-lc_treat4clr.jpg | GRAPHIC | 177648
20 | GRAPHIC | tm2225088d1-lc_activate4clr.jpg | GRAPHIC | 49124
21 | GRAPHIC | tm2225088d1-lc_immunec4clr.jpg | GRAPHIC | 86893
22 | GRAPHIC | tm2225088d1-pht_dendrit4clr.jpg | GRAPHIC | 144005
23 | GRAPHIC | tm2225088d1-lc_sensitve4clr.jpg | GRAPHIC | 80969
24 | GRAPHIC | tm2225088d1-lc_effects4clr.jpg | GRAPHIC | 129268
25 | GRAPHIC | lc_antitumor-4clr.jpg | GRAPHIC | 138275
26 | GRAPHIC | tm2225088d1-fc_platform4c.jpg | GRAPHIC | 150732
27 | GRAPHIC | tm2225088d1-pht_tech4c.jpg | GRAPHIC | 226819
28 | GRAPHIC | txt_adlainorty-bw.jpg | GRAPHIC | 19984
29 | GRAPHIC | txt_shanghi-bw.jpg | GRAPHIC | 21129
30 | GRAPHIC | txt_hangzhou-bw.jpg | GRAPHIC | 15164
| Complete submission text file | 0001104659-23-105297.txt |  | 10991052

Mailing Address 685 U.S. HIGHWAY ONE, 2ND FLOOR NORTH BRUNSWICK NJ 08902
Business Address 685 U.S. HIGHWAY ONE, 2ND FLOOR NORTH BRUNSWICK NJ 08902 848-230-7430
Adlai Nortye Ltd. (Filer) CIK: 0001944552 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-273465 | Film No.: 231295353
SIC: 2834 Pharmaceutical Preparations